Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β₁, and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia

References

• RowleyJDLetter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa stainingNature197324354052902934126434
   PubMed Web of Science ®Google Scholar
• KurzrockRKantarjianHMDrukerBJTalpazMPhiladelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeuticsAnn Intern Med20031381081983012755554
   PubMed Web of Science ®Google Scholar
• BortinMMHorowitzMMRowlingsPA1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant RegistryBone Marrow Transplant1993122971048401371
   PubMed Web of Science ®Google Scholar
• RousselotPHuguetFReaDImatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 yearsBlood20071091586016973963
   PubMed Web of Science ®Google Scholar
• JabbourEKantarjianHMSaglioGEarly response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)Blood2014123449450024311723
   PubMed Web of Science ®Google Scholar
• HughesTPSaglioGKantarjianHMEarly molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinibBlood201412391353136024335106
   PubMed Web of Science ®Google Scholar
• LaneuvillePWhen to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid LeukemiaCurr Treat Options Oncol20181931529520446
   PubMed Web of Science ®Google Scholar
• RixUHantschelODürnbergerGChemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targetsBlood2007110124055406317720881
   PubMed Web of Science ®Google Scholar
• LindauerMHochhausADasatinibRecent Results Cancer Res2014201276524756784
   PubMedGoogle Scholar
• MustjokiSEkblomMArstilaTPClonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyLeukemia20092381398140519295545
   PubMed Web of Science ®Google Scholar
• KimDHKamel-ReidSChangHNatural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemiaHaematologica200994113513919066329
   PubMed Web of Science ®Google Scholar
• SchifferCACortesJEHochhausALymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCancer201612291398140726998677
   PubMed Web of Science ®Google Scholar
• SakaguchiSNaturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responsesAnnu Rev Immunol20042253156215032588
   PubMed Web of Science ®Google Scholar
• von BoehmerHMechanisms of suppression by suppressor T cellsNat Immunol20056433834415785759
   PubMed Web of Science ®Google Scholar
• YuJHeckSPatelVDefective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpuraBlood200811241325132818420827
   PubMed Web of Science ®Google Scholar
• LiuMFWangCRChenPCFungLLIncreased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosusScand J Immunol200357656857212791095
   PubMed Web of Science ®Google Scholar
• NomuraSOzakiYIkedaYFunction and role of microparticles in various clinical settingsThromb Res2008123182318667228
   PubMed Web of Science ®Google Scholar
• NomuraSShimizuMClinical significance of procoagulant microparticlesJ Intens Care2015312
   PubMed Web of Science ®Google Scholar
• NomuraSMicroparticle and Atherothrombotic DiseasesJ Atheroscler Thromb20162311926412494
   PubMed Web of Science ®Google Scholar
• MiyazakiYNomuraSMiyakeTHigh shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticlesBlood1996889345634648896411
   PubMed Web of Science ®Google Scholar
• BaccaraniMCortesJPaneFEuropean LeukemiaNetChronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNetJ Clin Oncol200927356041605119884523
   PubMed Web of Science ®Google Scholar
• OsumiKOzekiYSaitoSDevelopment and assessment of enzyme immunoassay for platelet-derived microparticlesThromb Haemost200185232633011246556
   PubMed Web of Science ®Google Scholar
• ChangHKamel-ReidSHussainNLiptonJMessnerHAT-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disordersAm J Clin Pathol2005123219619915842042
   PubMed Web of Science ®Google Scholar
• ShahNPAdvanced CML: therapeutic options for patients in accelerated and blast phasesJ Natl Compr Canc Netw20086Suppl 2S31SS618397679
   PubMedGoogle Scholar
• SoveriniSManciniMBavaroLCavoMMartinelliGChronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapyMol Cancer20181714929455643
   PubMed Web of Science ®Google Scholar
• ShimazuTInamiNSatohDEffect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patientsJ Thromb Thrombolysis200928442943519137265
   PubMed Web of Science ®Google Scholar
• VillmowTKemkes-MatthesBMatzdorffACMarkers of platelet activation and platelet-leukocyte interaction in patients with myelo-proliferative syndromesThromb Res20021082-313914512590950
   PubMed Web of Science ®Google Scholar
• Quintás-CardamaAHanXKantarjianHCortesJTyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemiaBlood2009114226126319414863
   PubMed Web of Science ®Google Scholar
• MazharianAGhevaertCZhangLMassbergSWatsonSPDasatinib enhances megakaryocyte differentiation but inhibits platelet formationBlood2011117195198520621385851
   PubMed Web of Science ®Google Scholar
• MouzakiATheodoropoulouMGianakopoulosIVlahaVKyrtsonisMCManiatisAExpression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosisBlood200210051774177912176899
   PubMed Web of Science ®Google Scholar
• GuoCChuXShiYCorrection of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpuraJ Clin Immunol200727655756217619126
   PubMed Web of Science ®Google Scholar
• KreutzmanALadellKKoechelCExpansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivationLeukemia201125101587159721647156
   PubMed Web of Science ®Google Scholar
• LamyTLoughranTPLarge Granular Lymphocyte LeukemiaCancer Control1998512533
   PubMedGoogle Scholar
• QiuZYXuWLiJYLarge granular lymphocytosis during dasatinib therapyCancer Biol Ther201415324725524352048
   PubMed Web of Science ®Google Scholar
• SimoneRPesceGAntolaPThe soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responsesBiomed Res Int2014201421576324605322
   PubMed Web of Science ®Google Scholar
• GeroldKDZhengPRainbowDBZerneckeAWickerLSKisslerSThe soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell functionDiabetes20116071955196321602513
   PubMed Web of Science ®Google Scholar
• CrossDCambierJCTransforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expressionJ Immunol199014424324391688578
   PubMed Web of Science ®Google Scholar
• BridouxFBadouASaoudiATransforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell linesJ Exp Med199718510176917759151702
   PubMed Web of Science ®Google Scholar
• WanYYFlavellRA‘Yin-Yang’ functions of transforming growth factor-beta and T regulatory cells in immune regulationImmunol Rev200722019921317979848
   PubMed Web of Science ®Google Scholar
• VajenTMauseSFKoenenRRMicrovesicles from platelets: novel drivers of vascular inflammationThromb Haemost2015114222823625994053
   PubMed Web of Science ®Google Scholar